Product NDC: | 68180-202 |
Proprietary Name: | SUPRAX |
Non Proprietary Name: | CEFIXIME |
Active Ingredient(s): | 100 mg/5mL & nbsp; CEFIXIME |
Administration Route(s): | ORAL |
Dosage Form(s): | POWDER, FOR SUSPENSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 68180-202 |
Labeler Name: | Lupin Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065129 |
Marketing Category: | ANDA |
Start Marketing Date: | 20040301 |
Package NDC: | 68180-202-03 |
Package Description: | 50 mL in 1 BOTTLE (68180-202-03) |
NDC Code | 68180-202-03 |
Proprietary Name | SUPRAX |
Package Description | 50 mL in 1 BOTTLE (68180-202-03) |
Product NDC | 68180-202 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | CEFIXIME |
Dosage Form Name | POWDER, FOR SUSPENSION |
Route Name | ORAL |
Start Marketing Date | 20040301 |
Marketing Category Name | ANDA |
Labeler Name | Lupin Pharmaceuticals, Inc. |
Substance Name | CEFIXIME |
Strength Number | 100 |
Strength Unit | mg/5mL |
Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |